- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04690894
Erector Spinae Muscle Block Versus Caudal Block by Sonar in Pediatrics Undergoing Lower Abdominal Surgery
March 4, 2021 updated by: Shadwa Rabea Mohamed, Minia University
Ultrasound-guided Erector Spinae Muscle Block Versus Ultrasound-guided Caudal Block in Pediatric Patient Undergoing Lower Abdominal Surgery
this prospective randomized double blind controlled study was conducted on 60 child scheduled for lower abdominal surgery under general anesthesia.
the patients were randomly allocated into 3 parallel groups.group
(ESB) patients received ultrasound-guided erector spinae block in a dose of 0.4mg/ml of 0.25%bupivacaine between the 10th transverse process and erector spinae muscles.group(CB)
patients received ultrasound-guided caudal block in a dose of 2.5mg/kg of 0.25%bupivacaine.
group(CO) did,t received any block
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
on arrival of the patients to the operative theatre and after placement of the standard monitoring general inhalational anesthesia was induced by face mask with sevoflurane (4-8%) in oxygen after IV cannula was secured patients received 1mic/kg fentanyl and intubation was facilitated by 0.5mg/kg atracurium.
isoflurane 1-2% with oxygen was used for maintenance of anesthesia.
after stabilization of the patient's hemodynamics and before skin incision erector spinae block or caudal block was performed with the patient in lateral position.
after the block patients were flipped back to their normal supine position, surgery took place 10 min after injection of local anesthetic.
after termination of surgery reversal of the atracurium was done by giving neostigmine in a dose of 0.04mg/kg and atropine 0.02mg/kg and awake extubation was done
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Minya, Egypt, 61111
- Faculty of medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 6 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- pediatric patients aged 2-6 years scheduled for lower abdominal surgery under general anesthesia
Exclusion Criteria:
- parent refusal
- spinal and meningeal anomalies
- mental retardation
- blood disease
- infection at site of injection
- drug allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Erector spinae group
the child received ultrasound-guided erector spinae muscle block in a dose of 0.4mg/kg of 0.25%bupivacaine between the 10th transverse process and erector spinae muscle
|
the child placed in lateral position identification of spinous process of 10th thoracic vertebral then the transducer was moved 2.5 cm laterally to visualize the transverse process and a total of 0.4mg/kg of 0.25%bupivacaine was adminstered
|
Active Comparator: caudal group
child received ultrasound-guided caudal block in a dose of 2.5mg/kg of bupivacaine 0.25%
|
the child placed in lateral position identification of spinous process of 10th thoracic vertebral then the transducer was moved 2.5 cm laterally to visualize the transverse process and a total of 0.4mg/kg of 0.25%bupivacaine was adminstered
|
No Intervention: control
child didn't received any regional block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of patients need rescue analgesia
Time Frame: 24 hours
|
total number of patients need addition of anagesia
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
First analgesic request
Time Frame: 24 hours
|
First time that patient require analgesia
|
24 hours
|
Hemodynamic changes in the study period
Time Frame: 24 hours
|
Changes in HR and blood pressure
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ibrahim Talaat, MD, professor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2019
Primary Completion (Actual)
January 15, 2020
Study Completion (Actual)
February 15, 2020
Study Registration Dates
First Submitted
December 28, 2020
First Submitted That Met QC Criteria
December 28, 2020
First Posted (Actual)
December 31, 2020
Study Record Updates
Last Update Posted (Actual)
March 8, 2021
Last Update Submitted That Met QC Criteria
March 4, 2021
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 266:7/2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Analgesia
-
Cukurova UniversityCompleted
-
Suez Canal UniversityCompleted
-
Tanta UniversityCompleted
-
Ain Shams UniversityCompleted
-
Minia UniversityCompletedPostoperative AnalgesiaEgypt
-
Assiut UniversityUnknown
-
Istanbul UniversityCompletedPostoperative Analgesia
-
Assiut UniversityCompletedPostoperative Analgesia
-
National Cancer Institute, EgyptNational Cancer Institute (NCI)Not yet recruitingPostoperative Analgesia
-
Second Hospital of Jilin UniversityCompletedPostoperative AnalgesiaChina
Clinical Trials on erector spinae block - caudal block
-
National Cancer Institute, EgyptRecruiting
-
Abant Izzet Baysal UniversityKarabuk University; Basaksehir Cam & Sakura Şehir HospitalRecruitingInguinal Hernia | Post Operative PainTurkey
-
Tanta UniversityCompletedEfficacy of Erector Spinae Plane Block in Lower Limb Surgery in PediatricEgypt
-
Cairo UniversityCompletedAcute Postoperative PainEgypt
-
Tanta UniversityUnknownConventional Caudal Block | Ultrasound Guided Caudal Block | Ultrasound Guided Erector Spinae Block | Pediatric Hip SurgeryEgypt
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPost Operative Pain | Stress Response | Erector Spinae Plane Block | Caudal BlockTurkey
-
Giresun UniversityRecruitingPain, Postoperative | Nerve Block | Urogenital DiseasesTurkey
-
Tanta UniversityCompletedCaudal Block | Pediatrics | Sacral Erector Spinae Plane Block | Penile SurgeriesEgypt
-
University of ManitobaDr. Ian SurdharCompletedNerve Block | Rib FracturesCanada